doxazosin has been researched along with Deficiency, Vitamin E in 1 studies
Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Doxazosin treatment prevented the impairment in endothelium-dependent vascular relaxation in the high cholesterol/antioxidant-deficient group." | 1.30 | Effect of doxazosin on endothelial dysfunction in hypercholesterolemic/antioxidant-deficient rats. ( Coffee, K; Guerra, J; Hayakawa, H; Raij, L, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raij, L | 1 |
| Hayakawa, H | 1 |
| Coffee, K | 1 |
| Guerra, J | 1 |
1 other study available for doxazosin and Deficiency, Vitamin E
| Article | Year |
|---|---|
Effect of doxazosin on endothelial dysfunction in hypercholesterolemic/antioxidant-deficient rats.
Topics: Adrenergic alpha-Antagonists; Animals; Antioxidants; Body Weight; Doxazosin; Endothelium, Vascular; | 1997 |